Caladria is a precision neuromedicine company focused on using an unbiased human data-driven approach to discover and develop novel therapeutics for neurodegenerative diseases. Co-Founder and Chief Scientific Officer Dr. Jonathan Grima is one of the world’s leading experts in the Nuclear Pore Hypothesis in neurodegeneration, for which he was awarded Forbes Top 30 under 30 in science (2019). Dr. Grima and his team are discovering new pathways and clinical assets in neurodegenerative diseases based on his discovery and previous research at Johns Hopkins University.

Dr. Grima is supported by a team of business visionaries, drug development and commercialization executives, legal experts, neuroscience and AI/ML experts and world leaders in neurodegenerative disease as scientific advisors.

Event details

Date: January 9 - 11, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


13 in total